Novo Nordisk

Addressing our environmental impact as we grow remains a challenge, but we continue to invest in solutions to speed up our transition towards a more sustainable future. Thanks Corporate Knights for ranking us as one of the 100 Most Sustainable Corporations in the World - 2025. It is certainly work in progress, but rankings like yours help set global sustainability standards while holding us accountable to our commitment to do more with less. Curious to learn more about our actions? Read more here: https://lnkd.in/du-kF-QE  #DrivingChange #Sustainability

We have just been ranked among the top 50 all-stars in Fortune's World's Most Admired Companies – and as the second most admired pharmaceutical company. These recognitions reflect our dedication to improving lives through innovation and our commitment to corporate responsibility.   If you also want to make a difference and help shape the future of health, you can explore career opportunities here: https://lnkd.in/dfHdaYP #MostAdmiredCompanies

We’re proud to support 13th Avenue School in Newark, New Jersey in their mission to educate students on healthy eating habits and combat food deserts in the area. Schools are critical to driving positive change in student and community well-being. By providing education about healthy food consumption and expanding access to nutritious food across the district, schools can help address this critical need for the next generation. Chesha Hodge, MPA RDN, Director for the Coalition for Healthy Food in Newark Schools, shares more about the impactful work being done. Learn more about our commitment to serve local communities: https://bit.ly/4asP46Y #NovoNordiskUS #DrivingChange

We’re working with cities around the world to create healthier urban environments ⚽️🍊🚲    From cycling initiatives for children to tackling childhood obesity, here is how Cities for Better Health is making a difference.     Learn more about the 2024 progress here: https://lnkd.in/djdC9V29 

We are significantly expanding our collaboration with Valo Health to discover and develop novel treatments for cardiometabolic diseases, using large-scale human data and AI. Together, we aim to advance up to 20 drug development programs in obesity, type 2 diabetes, and cardiovascular disease. Find all details about the expanded collaboration in our press release here: https://lnkd.in/dttDY5a7 #NovoNordisk #Partnership #DrivingChange 

Season's Greetings from us to all of you! Before we step into 2025, let’s look back on an eventful 2024 together. We’re excited to share more moments with you in the new year! 💙 #NovoNordisk #DrivingChange 

As we approach the end of the year, we reach an important milestone with the completion of our acquisition of three manufacturing sites from Novo Holdings. This follows the finalisation of Novo Holdings’ acquisition of Catalent Pharma Solutions, a global contract development and manufacturing organisation headquartered in New Jersey (US).   “We are very pleased with the completion of the acquisition. The three sites will expand our manufacturing capacity at scale and speed, while complementing our ongoing significant internal supply chain expansions. The acquisition will enable us to reach significantly more people living with serious chronic diseases”, says our CEO and president Lars Fruergaard Jørgensen.   Curious to know more? Get all the details in our company announcement here https://lnkd.in/gu4MH2U #NovoNordisk #DrivingChange

We are launching a 2-week minimum caregiver leave for all employees globally from the beginning of the new year. Because we believe that supporting our people when they need it most isn't just a benefit— it's a fundamental part of who we are.   A caregiver is any colleague who provides physical, psychological, or emotional support to their dependent who has a serious health condition. This is important, so we all have the opportunity to achieve a good work/life balance while managing multiple priorities. Especially when life is difficult.   Kathy, our US colleague and a benefits manager, leaned on our caregiver benefits, which were already in place in the US. The leave gave her the time and space to prioritise what truly mattered: being there for her husband, William, during his battle with cancer.     “Our benefits allow us to be human to one another. They allow us the grace to do what we have to do – and that means understanding that there are times in our lives when work should not interfere with that."     Thank you, Kathy, for sharing your story. We know how much it means to you and your work to share this benefit with as many as possible. Read more about the caregiver leave here: https://lnkd.in/dnGzZN8Y    #Caregiver #EmployeeBenefits #NovoNordisk

We're investing in a new production facility in Odense, Denmark - the first new site we’ve built in Denmark this century. The new facility will help produce treatments for rare diseases, including haemophilia, using advanced technology and innovation. The site will also be in sustainable design with a commitment to preserve the nature in the area. Scheduled for completion in 2027, it will create 400 permanent jobs and support growing global demand for life-changing medicines. We’re proud to expand our heritage in Denmark and look forward to contributing to the community in Odense! Learn more here 👉 https://lnkd.in/gu4MH2U #NovoNordisk #DrivingChange #Production #Innovation

In the early 2000s, three of our scientists embarked on a groundbreaking journey to reduce the treatment burden for people living with type 2 diabetes. Their goal was simple. They wanted to develop a treatment that only required to be injected once every week, instead of once every day, and that was a huge scientific challenge. With relentless dedication, experimentation, and hundreds of compounds screened they arrived at a technology suitable for engineering a once-weekly compound. Today, we proudly celebrate Jesper Lau, Thomas Kruse, and Paw Bloch as co-recipients of the 2024 Inventor of the Year Award by the IPO Education Foundation.  Please join us in celebrating the three inventors!   #DrivingChange #LifeSciences #IPOEFAwards #InventorOfTheYear #IntellectualProperty